Zobrazeno 1 - 10
of 1 277
pro vyhledávání: '"Fujihara K"'
Autor:
Tian, K., Tay, T.E., Tan, V.B.C., Haris, A., Chew, Enquan, Pham, V.N.H., Huang, J.Z., Raju, K., Sugahara, T., Fujihara, K., Zushi, H., Liu, J.L.
Publikováno v:
In Composites Part A August 2023 171
Autor:
Matsubayashi, Y., Yoshida, A., Suganami, H., Ishiguro, H., Yamamoto, M., Fujihara, K., Kodama, S., Tanaka, S., Kaku, K., Sone, H.
Publikováno v:
In Diabetes and Metabolism March 2018 44(2):135-142
Autor:
Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Bennett, J.L., Kim, H.J., Pittock, S.J., Fujihara, K., Paul, F., Cutter, G., Marignier, R., Aktas, O., Hartung, H.P., She, D., Smith, M., Rees, W., Patterson, K., Cimbora, D., Katz, E., Cree, B.A.
BACKGROUND: The N-MOmentum trial investigated safety and efficacy of inebilizumab in participants with neuromyelitis optica spectrum disorder (NMOSD). OBJECTIVE: Evaluate the attack identification process and adjudication committee (AC) performance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::a746e595172eb6dff4232bbfe3f3338f
http://edoc.mdc-berlin.de/23520/1/23520oa.pdf
http://edoc.mdc-berlin.de/23520/1/23520oa.pdf
Autor:
Sekiya, N., Fujihara, K.
Publikováno v:
In Physica C: Superconductivity and its applications 15 November 2016 530:117-119
Autor:
Aktas, O., Hartung, H.P., Smith, M.A., Rees, W.A., Fujihara, K., Paul, F., Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Cutter, G., She, D., Gunsior, M., Cimbora, D., Katz, E., Cree, B.A.
OBJECTIVE: To investigate relationships between serum neurofilament light chain (sNfL), ubiquitin C-terminal hydrolase L1 (sUCHL1), tau (sTau) and glial fibrillary acidic protein (sGFAP) levels and disease activity/disability in neuromyelitis optica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::2a1728150bca8f01c7f49e65bdb611df
http://edoc.mdc-berlin.de/23383/1/23383oa.pdf
http://edoc.mdc-berlin.de/23383/1/23383oa.pdf
Publikováno v:
In Separation and Purification Technology 17 December 2015 156 Part 1:84-91
Autor:
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F., Pittock, S.J.
INTRODUCTION: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease defined by attacks on the central nervous system that cause irreversible damage. Recent approval of NMOSD therapies warrants investigations of comparative efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::492452d11cddf3e9d5477d3ee3883adf
http://edoc.mdc-berlin.de/21066/1/21066oa.pdf
http://edoc.mdc-berlin.de/21066/1/21066oa.pdf
Autor:
Petzold, A., Albrecht, P., Balcer, L., Bekkers, E., Brandt, A. U., Calabresi, P. A., Deborah, O. G., Graves, J. S., Green, A., Keane, P. A., Nij Bijvank, J. A., Sander, J. W., Paul, F., Saidha, S., Villoslada, P., Wagner, S. K., Yeh, E. A., Aktas, O., Antel, J., Asgari, N., Audo, I., Avasarala, J., Avril, D., Bagnato, F. R., Banwell, B., Bar-Or, A., Behbehani, R., Manterola, A. B., Bennett, J., Benson, L., Bernard, J., Bremond-Gignac, D., Britze, J., Burton, J., Calkwood, J., Carroll, W., Chandratheva, A., Cohen, J., Comi, G., Cordano, C., Costa, S., Costello, F., Courtney, A., Cruz-Herranz, A., Cutter, G., Crabb, D., Delott, L., De Seze, J., Diem, R., Dollfuss, H., El Ayoubi, N. K., Fasser, C., Finke, C., Fischer, D., Fitzgerald, K., Fonseca, P., Frederiksen, J. L., Frohman, E., Frohman, T., Fujihara, K., Cuellar, I. G., Galetta, S., Garcia-Martin, E., Giovannoni, G., Glebauskiene, B., Suarez, I. G., Jensen, G. P., Hamann, S., Hartung, H. -P., Havla, J., Hemmer, B., Huang, S. -C., Imitola, J., Jasinskas, V., Jiang, H., Kafieh, R., Kappos, L., Kardon, R., Keegan, D., Kildebeck, E., Kim, U. S., Klistorner, S., Knier, B., Kolbe, S., Korn, T., Krupp, L., Lagreze, W., Leocani, L., Levin, N., Liskova, P., Preiningerova, J. L., Lorenz, B., May, E., Miller, D., Mikolajczak, J., Said, S. M., Montalban, X., Morrow, M., Mowry, E., Murta, J., Navas, C., Nolan, R., Nowomiejska, K., Oertel, F. C., Oh, J., Oreja-Guevara, C., Orssaud, C., Osborne, B., Outteryck, O., Paiva, C., Palace, J., Papadopoulou, A., Patsopoulos, N., Pontikos, N., Preising, M., Prince, J., Reich, D., Rejdak, R., Ringelstein, M., Rodriguez de Antonio, L., Sahel, J. -A., Sanchez-Dalmau, B., Sastre-Garriga, J., Schippling, S., Schuman, J., Shindler, K., Shin, R., Shuey, N., Soelberg, K., Specovius, S., Suppiej, A., Thompson, A., Toosy, A., Torres, R., Touitou, V., Trauzettel-Klosinski, S., van der Walt, A., Vermersch, P., Vidal-Jordana, A., Waldman, A. T., Waters, C., Wheeler, R., White, O., Wilhelm, H., Winges, K. M., Wiegerinck, N., Wiehe, L., Wisnewski, T., Wong, S., Wurfel, J., Yaghi, S., You, Y., Yu, Z., Yu-Wai-Man, P., Zemaitien≐, R., Zimmermann, H.
Publikováno v:
Petzold, A, Albrecht, P, Balcer, L, Bekkers, E, Brandt, A U, Calabresi, P A, Deborah, O G, Graves, J S, Green, A, Keane, P A, Nij Bijvank, J A, Sander, J W, Paul, F, Saidha, S, Villoslada, P, Wagner, S K, Yeh, E A & the IMSVISUAL, ERN-EYE Consortium 2021, ' Artificial intelligence extension of the OSCAR-IB criteria ', Annals of Clinical and Translational Neurology, vol. 8, no. 7, pp. 1528-1542 . https://doi.org/10.1002/acn3.51320
the IMSVISUAL, ERN-EYE Consortium 2021, ' Artificial intelligence extension of the OSCAR-IB criteria ', Annals of Clinical and Translational Neurology, vol. 8, no. 7, pp. 1528-1542 . https://doi.org/10.1002/acn3.51320
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 8, Iss 7, Pp 1528-1542 (2021)
the IMSVISUAL, ERN-EYE Consortium 2021, ' Artificial intelligence extension of the OSCAR-IB criteria ', Annals of Clinical and Translational Neurology, vol. 8, no. 7, pp. 1528-1542 . https://doi.org/10.1002/acn3.51320
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 8, Iss 7, Pp 1528-1542 (2021)
Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab75a15c7ed188859f7ddc8d47650216
https://openaccess.city.ac.uk/id/eprint/26361/1/acn3.51320.pdf
https://openaccess.city.ac.uk/id/eprint/26361/1/acn3.51320.pdf
Autor:
Marignier, R., Pittock, S.J., Paul, F., Kim, H.J., Bennett, J. L., Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Fujihara, K., Cutter, G., Aktas, O., Hartung, H.P., Drappa, J., Ratchford, J.N., She, D., Smith, M., Rees, W., Cimbora, D., Katz, E., Cree, B.A.C.
BACKGROUND: The N-MOmentum trial, a double-blind, randomized, placebo-controlled, phase 2/3 study of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD), enrolled participants who were aquaporin-4-immunoglobulin G (AQP4-IgG)-seropositive (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::3790c54a309d062eb54f13981d7e7a63
http://edoc.mdc-berlin.de/21053/2/21053suppl.doc
http://edoc.mdc-berlin.de/21053/2/21053suppl.doc
Autor:
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Ratchford, J.N., Katz, E.
BACKGROUND: In the N-MOmentum trial, the risk of an adjudicated neuromyelitis optica spectrum disorder (NMOSD) attack was significantly reduced with inebilizumab compared with placebo. OBJECTIVE: To demonstrate the robustness of this finding, using p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::0d6e9bbd8f2482d3144b68ef8a05d4f5
http://edoc.mdc-berlin.de/19976/1/19976oa.pdf
http://edoc.mdc-berlin.de/19976/1/19976oa.pdf